Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.
Tagged pharmaceuticals · clear
Written by : Eric Furman, Ph.D. and Ashley C. Morales Key Takeaway: Federal Circuit invalidates patent claims directed to a method for treating non-small cell lung cancer through administration of “a unit dosage” of an irreversible epidermal…
Written by : Jason J. Jardine and Kenneth O. Aruda, Ph.D. Key Takeaway: The term “about” remains useful in biotech and pharmaceutical claims, but only if the patent provides objective guidance about what the term means. Absent that guidance,…
Written by : J ason J. Jardine and Lizzy T. Do Key Takeaway: Amendments to Mexico’s Federal Law for Protection of Industrial Property align more with U.S. Patent and Trademark Office standards for restoring priority and application revival,…
Written by : Ari Feinstein and Zoe E. Vikstrom HIKMA PHARMACEUTICALS USA INC. et al. v. AMARIN PHARMA, INC., et al. Jackson, J., delivered the opinion for a unanimous Court. Certiorari to the United States Court of Appeals for the Federal Circuit. Summary:…
Written by : Agnes Juang, Ph.D. and Ashley C. Morales Key Takeaway: Genetically engineered cultured host cells containing recombinant nucleic acids useful for gene therapy are patent-eligible for being markedly different from anything occurring in nature.…
Written by : Ben K. Shiroma and Alistair J. McIntyre TEVA PHARMACEUTICALS INTERNATIONAL GMBH v. ELI LILLY AND COMPANY Before Prost , Cunningham, and Andrews. Appeal from the United States District Court of the District of Massachusetts. Summary : A…
Written by : Jeremiah S. Helm, Ph.D. ASCENDIS PHARMA A/S v. BIOMARIN PHARMACEUTICAL INC. Before Lourie, Chen, and Stoll . Appeal from the United States District Court for the Northern District of California. Summary : A respondent in an ITC proceeding may…
Written by : Ari Feinstein and Sophia Zahn On December 5, 2025, the Skinny Labels, Big Savings Act (H.R. 6485) was introduced in the House of Representatives. The bill, if enacted, would shield certain drug manufacturers who have submitted drug…
Written by : Ari Feinstein and Sophia Zahn On December 5, 2025, the Skinny Labels, Big Savings Act (H.R. 6485) was introduced in the House of Representatives. The bill, if enacted, would shield certain drug manufacturers who have submitted drug…
Written by : Robert J. Hilton, Ph.D. and Susan M. Janicki, Ph.D. On November 26, 2025, the United States Patent and Trademark Office (USPTO) issued revised guidelines for determining inventorship of AI-assisted inventions, [1] which is a significant…
Written by : Jason J. Jardine and Geetha Durairaj, Ph.D. In October 2025, the U.S. Patent and Trademark Office (USPTO) launched the “ Artificial Intelligence Search Automated Pilot Program ,” or ASAP!, an initiative to identify potential prior…
Written by : Justin J. Gillett and Kenneth O. Aruda, Ph.D. GLOBAL HEALTH SOLUTIONS LLC v. SELNER Before Stoll, Stark , and Goldberg (sitting by designation). Appeal from the Patent Trial and Appeal Board. Summary : The Federal Circuit affirmed the…
